Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-057814
Filing Date
2026-02-18
Accepted
2026-02-18 20:47:13
Documents
1
Period of Report
2026-02-15

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 10380
  Complete submission text file 0001193125-26-057814.txt   11883
Mailing Address 209 CHURCH STREET NEW HAVEN CT 06510
Business Address 209 CHURCH STREET NEW HAVEN CT 06510 (781) 819-0080
Invivyd, Inc. (Issuer) CIK: 0001832038 (see all company filings)

EIN.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O INVIVYD, INC. 209 CHURCH STREET NEW HAVEN CT 06510
Business Address
Andersen Jill (Reporting) CIK: 0001891047 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40703 | Film No.: 26651215